or Try an Advanced Search...

    Technical Analysis for VRDN - Viridian Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 13.21 1.54% 0.20
    VRDN closed up 1.54 percent on Monday, July 1, 2024, on 63 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Flat Up
    Historical VRDN trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Up 3 Days in a Row Strength 0.00%
    Pocket Pivot Bullish Swing Setup 1.54%
    BB Squeeze Ended Range Expansion 1.54%
    Crossed Above 20 DMA Bullish 3.36%
    Bollinger Band Squeeze Range Contraction 3.36%
    BB Squeeze Started Range Contraction 3.36%
    Fell Below 20 DMA Bearish 7.31%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.53%
    NR7 Range Contraction 3.53%
    Older End-of-Day Signals for VRDN ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above 50 DMA about 9 hours ago
    Up 2% about 9 hours ago
    Up 1% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    VRDN Chart by TradingView
    Basic chart:

    Profile

    Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado, with research and development operations in Waltham, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biotechnology Biology Monoclonal Antibody Thyroid Eye Disease

    Is VRDN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 Viridian Therapeutics: Key Catalysts Coming In The Second Half Of The Year
    Jun 11 Viridian gains after R&D update; Wolfe starts at Outperform
    Jun 11 Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease
    May 31 Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
    May 10 Viridian Therapeutics to Participate in Upcoming May Investor Conferences
    May 9 Viridian Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    May 9 Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
    May 8 Viridian Therapeutics, Inc. (VRDN) Q1 2024 Earnings Call Transcript
    May 8 Viridian Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
    May 8 Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings: Narrowing Losses Amidst Clinical Advancements
    See more VRDN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 24.84
    52 Week Low 10.925
    Average Volume 1,036,297
    200-Day Moving Average 16.28
    50-Day Moving Average 13.19
    20-Day Moving Average 12.54
    10-Day Moving Average 12.66
    Average True Range 0.74
    RSI (14) 53.70
    ADX 16.16
    +DI 27.02
    -DI 19.09
    Chandelier Exit (Long, 3 ATRs) 11.96
    Chandelier Exit (Short, 3 ATRs) 13.61
    Upper Bollinger Bands 13.48
    Lower Bollinger Band 11.61
    Percent B (%b) 0.86
    BandWidth 14.86
    MACD Line -0.09
    MACD Signal Line -0.23
    MACD Histogram 0.1468
    Fundamentals Value
    Market Cap 789.02 Million
    Num Shares 59.7 Million
    EPS -5.14
    Price-to-Earnings (P/E) Ratio -2.57
    Price-to-Sales 3322.96
    Price-to-Book 7.22
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 13.91
    Resistance 3 (R3) 13.88 13.62 13.79
    Resistance 2 (R2) 13.62 13.45 13.64 13.75
    Resistance 1 (R1) 13.42 13.34 13.52 13.44 13.71
    Pivot Point 13.16 13.16 13.21 13.17 13.16
    Support 1 (S1) 12.95 12.98 13.06 12.98 12.71
    Support 2 (S2) 12.69 12.87 12.71 12.67
    Support 3 (S3) 12.49 12.69 12.63
    Support 4 (S4) 12.51